Patents by Inventor Mei-Guey Lei

Mei-Guey Lei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purified mammalian cell binding receptor for bacterial lipopolysaccharide endotoxin and monoclonal antibody
    Patent number: 5045466
    Abstract: The invention is directed to hydridoma cell lines and the monoclonal antibodies produced by the cell lines, where the monoclonal antibodies specifically bind to the lipopolysaccharide endotoxin binding receptor of mammalian cells. Specifically, the monoclonal antibodies binds to a cell receptor which has a molecular mass of 80 kilodaltons, and is specific for the lipid A component of the lipopolysaccharide endotoxin. The monoclonal antibodies are specific for a carbohydrate component of the binding receptor in one instance, and for a protein/peptide receptor in another.
    Type: Grant
    Filed: July 7, 1989
    Date of Patent: September 3, 1991
    Assignee: University of Kansas
    Inventors: David C. Morrison, Taiying Chen, Mei-Guey Lei, Stuart W. Bright, Linda M. Flebbe